| 000 | 01353 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511211009.0 | ||
| 264 | 0 | _c19910913 | |
| 008 | 199109s 0 0 eng d | ||
| 022 | _a0306-5251 | ||
| 024 | 7 |
_a10.1111/j.1365-2125.1991.tb05594.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWard, S A | |
| 245 | 0 | 0 |
_aThe activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism--a panel study. _h[electronic resource] |
| 260 |
_bBritish journal of clinical pharmacology _cJun 1991 |
||
| 300 |
_a689-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMephenytoin _xmetabolism |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aProguanil _xurine |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 |
_aSparteine _xmetabolism |
| 650 | 0 | 4 |
_aTriazines _xurine |
| 700 | 1 | _aHelsby, N A | |
| 700 | 1 | _aSkjelbo, E | |
| 700 | 1 | _aBrøsen, K | |
| 700 | 1 | _aGram, L F | |
| 700 | 1 | _aBreckenridge, A M | |
| 773 | 0 |
_tBritish journal of clinical pharmacology _gvol. 31 _gno. 6 _gp. 689-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2125.1991.tb05594.x _zAvailable from publisher's website |
| 999 |
_c1874166 _d1874166 |
||